Clinical trial
Efficacy of Lactobacillus Reuteri in Managing Social Deficits in Children With Autistic Spectrum Disorder: a Randomized Clinical Trial With Evaluation of Gut Microbiota and Metabolomics Profiles
NCT04293783 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Lactobacillus Reuteri in Managing Social Deficits in Children With Autistic Spectrum Disorder: a Randomized Clinical Trial With Evaluation of Gut Microbiota and Metabolomics Profiles
- Lead sponsor
- University of Rome Tor Vergata
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2020
- Completion date
- August 30, 2021
- Enrollment
- 43 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.